• Citer

Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.

par Bouwhuis, Marna G;Suciu, Stefan ;Collette, Sandra;Aamdal, S;Kruit, Wim H;Bastholt, Lars;Stierner, Ulrika;Sales, François ;Patel, Poulam;Punt, Cornelis;Hernberg, Micaela;Spatz, Alain;ten Hagen, Timo L M;Hansson, Johan;Eggermont, A;EORTC Melanoma Group and the Nordic Melanoma Group,
Référence Journal of the National Cancer Institute, 101, 12, page (869-877)
Publication Publié, 2009-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.
Auteur:	Bouwhuis, Marna G; Suciu, Stefan; Collette, Sandra; Aamdal, S; Kruit, Wim H; Bastholt, Lars; Stierner, Ulrika; Sales, François; Patel, Poulam; Punt, Cornelis; Hernberg, Micaela; Spatz, Alain; ten Hagen, Timo L M; Hansson, Johan; Eggermont, A; EORTC Melanoma Group and the Nordic Melanoma Group,
Informations sur la publication:	Journal of the National Cancer Institute, 101, 12, page (869-877)
Statut de publication:	Publié, 2009-06
Sujet CREF:	Cancérologie
MeSH keywords:	Adjuvants, Immunologic -- administration & dosage -- therapeutic use
	Adult
	Aged
	Antibodies, Anticardiolipin -- blood
	Antibodies, Antinuclear -- blood
	Autoantibodies -- blood
	Bias (Epidemiology)
	Confounding Factors (Epidemiology)
	Disease-Free Survival
	Enzyme-Linked Immunosorbent Assay
	Female
	Humans
	Interferon-alpha -- administration & dosage -- therapeutic use
	Male
	Melanoma -- drug therapy -- immunology
	Middle Aged
	Odds Ratio
	Proportional Hazards Models
	Randomized Controlled Trials as Topic
	Skin Neoplasms -- drug therapy -- immunology
	Time Factors
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0027-8874
	info:doi/10.1093/jnci/djp132
	info:pii/djp132
	info:scp/67449138506
	info:pmid/19509353